{"title":"[Outline of Metabolism and Nutrition Section in Clinical Laboratory Examination Guideline JSLM2015].","authors":"Hiroshi Yoshida","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The metabolism and nutrition section of JSLM2015 was constructed following the previous version JSLM2012. The examinations of dyslipidemia and glucose metabolism and weight loss and obesity were described in the first chapter Laboratory data approach and the second chapter Symptoms, respectively. Dyslipidemia, diabetes, gout and hyperuricemia, and osteoporosis were described in the third chapter Diseas- es. This paper provides an outline with a focus on dyslipidemia examination and dyslipidemia in the first and third chapters, respectively. [Review].</p>","PeriodicalId":21457,"journal":{"name":"Rinsho byori. The Japanese journal of clinical pathology","volume":"65 3","pages":"309-313"},"PeriodicalIF":0.0000,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rinsho byori. The Japanese journal of clinical pathology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The metabolism and nutrition section of JSLM2015 was constructed following the previous version JSLM2012. The examinations of dyslipidemia and glucose metabolism and weight loss and obesity were described in the first chapter Laboratory data approach and the second chapter Symptoms, respectively. Dyslipidemia, diabetes, gout and hyperuricemia, and osteoporosis were described in the third chapter Diseas- es. This paper provides an outline with a focus on dyslipidemia examination and dyslipidemia in the first and third chapters, respectively. [Review].
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
